SomaLogic, Inc.
NASDAQ:SLGC
2.1 (USD) • At close January 5, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | SomaLogic, Inc. |
Symbool | SLGC |
Munteenheid | USD |
Prijs | 2.1 |
Beurswaarde | 396,225,917 |
Dividendpercentage | 0% |
52-weken bereik | 1.73 - 3.79 |
Industrie | Health Information Services |
Sector | Healthcare |
CEO | Mr. Adam Taich |
Website | https://www.somalogic.com |
An error occurred while fetching data.
Over SomaLogic, Inc.
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)